Nomenclature	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=373	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=374	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=375	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=376	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=377
HGNC, UniProt	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:5297, http://www.uniprot.org/uniprot/P46098	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:5298, http://www.uniprot.org/uniprot/O95264	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:24003, http://www.uniprot.org/uniprot/Q8WXA8	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:24004, http://www.uniprot.org/uniprot/Q70Z44	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:24005, http://www.uniprot.org/uniprot/A5X5Y0
Functional Characteristics	γ= 0.4‐0.8 pS [+ 5‐HT3B, γ= 16 pS]; inwardly rectifying current [+ 5‐HT3B, rectification reduced]; nH 2‐3 [+ 5‐HT3B 1‐2]; relative permeability to divalent cations reduced by co‐expression of the 5‐HT3B subunit	γ= 0.4‐0.8 pS [+ 5‐HT3B, γ= 16 pS]; inwardly rectifying current [+ 5‐HT3B, rectification reduced]; nH 2‐3 [+ 5‐HT3B 1‐2]; relative permeability to divalent cations reduced by co‐expression of the 5‐HT3B subunit	–	–	–